BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10700719)

  • 41. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.
    Pfeifer M; Verhovec R; Zizek B; Prezelj J; Poredos P; Clayton RN
    J Clin Endocrinol Metab; 1999 Feb; 84(2):453-7. PubMed ID: 10022400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency.
    Malik IA; English PJ; Ghatei MA; Bloom SR; MacFarlane IA; Wilding JP
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):137-41. PubMed ID: 14678299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency.
    Ozbey N; Algun E; Turgut AS; Orhan Y; Sencer E; Molvalilar S
    Int J Obes Relat Metab Disord; 2000 May; 24(5):619-26. PubMed ID: 10849585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
    Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
    Franco C; Johannsson G; Bengtsson BA; Svensson J
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of growth hormone treatment on arginine to asymmetric dimethylarginine ratio and endothelial function in patients with growth hormone deficiency.
    Setola E; Monti LD; Lanzi R; Lucotti P; Losa M; Gatti E; Galluccio E; Oldani M; Fermo I; Giovannelli M; Bosi E; Piatti P
    Metabolism; 2008 Dec; 57(12):1685-90. PubMed ID: 19013291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
    Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.
    Malik IA; Foy P; Wallymahmed M; Wilding JP; MacFarlane IA
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):75-81. PubMed ID: 12807507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency.
    Snyder PJ; Biller BM; Zagar A; Jackson I; Arafah BM; Nippoldt TB; Cook DM; Mooradian AD; Kwan A; Scism-Bacon J; Chipman JJ; Hartman ML
    J Bone Miner Res; 2007 May; 22(5):762-70. PubMed ID: 17280527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy.
    Mohn A; Marzio D; Giannini C; Capanna R; Marcovecchio M; Chiarelli F
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):537-42. PubMed ID: 16268806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.
    Al-Shoumer KA; Ali K; Anyaoku V; Niththyananthan R; Johnston DG
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):171-8. PubMed ID: 8881449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term growth hormone replacement therapy in hypopituitary adults.
    Verhelst J; Abs R
    Drugs; 2002; 62(16):2399-412. PubMed ID: 12396230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
    Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
    Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
    Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
    Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.